Abstract Number: 1620 • 2016 ACR/ARHP Annual Meeting
Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MEDI4920, a Novel, Engineered CD40 Ligand Antagonist, in Healthy Volunteers
Background/Purpose: Fifty-six healthy adult male subjects were randomized in the study at a single site and administered either placebo or MEDI4920 (3, 10, 30, 100,…
ACR Meeting Abstracts